These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34367963)

  • 21. Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.
    Lin Y; Li D; Hui H; Miao H; Luo M; Roy B; Chen B; Zhang W; Shao D; Ma D; Jie Y; Qiu F; Li H; Jiang B
    Front Oncol; 2024; 14():1389618. PubMed ID: 38803537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinoma.
    Bai L; Huo R; Fang G; Ma T; Shang Y
    Front Oncol; 2023; 13():1055122. PubMed ID: 36756152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma.
    Gong Z; Jia Q; Chen J; Diao X; Gao J; Wang X; Zhu B
    J Thorac Oncol; 2019 May; 14(5):857-866. PubMed ID: 30768970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of the immune microenvironment associated with RRM2 expression and its application to PD-L1/PD-1 inhibitors in lung adenocarcinoma.
    Lee SK; Hwang Y; Han JH; Haam S; Lee HW; Koh YW
    Am J Cancer Res; 2023; 13(11):5443-5454. PubMed ID: 38058821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
    Wang Z; Wang C; Lin S; Yu X
    Front Oncol; 2021; 11():725292. PubMed ID: 34513703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
    Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
    Front Oncol; 2021; 11():633420. PubMed ID: 33747955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung adenocarcinoma patients with KEAP1 mutation harboring low immune cell infiltration and low activity of immune environment.
    Cheng W; Xu B; Zhang H; Fang S
    Thorac Cancer; 2021 Sep; 12(18):2458-2467. PubMed ID: 34328274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma.
    Behrens C; Rocha P; Parra ER; Feng L; Rodriguez-Canales J; Solis LM; Mino B; Zhang J; Gibbons DL; Sepesi B; Rice D; Heymach JV; Moran C; Creighton CJ; Lee JJ; Kadara H; Wistuba II
    Clin Lung Cancer; 2021 May; 22(3):e415-e424. PubMed ID: 32763065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.
    Zhang W; Li Y; Lyu J; Shi F; Kong Y; Sheng C; Wang S; Wang Q
    Cancer Sci; 2022 Mar; 113(3):891-903. PubMed ID: 34967077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Investigation of the Immune Microenvironment and Genome during Lung Adenocarcinoma Development.
    Wang Q; Xie B; Sun J; Li Z; Xiao D; Tao Y; She X
    J Cancer; 2024; 15(6):1687-1700. PubMed ID: 38370388
    [No Abstract]   [Full Text] [Related]  

  • 32. A signature-based classification of lung adenocarcinoma that stratifies tumor immunity.
    Zhang X; Jiang D; Li S; Zhang X; Zheng W; Cheng B
    Front Oncol; 2022; 12():1023833. PubMed ID: 36713530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Wen Y; Lin A; Zhu W; Wei T; Luo P; Guo L; Zhang J
    Front Pharmacol; 2021; 12():645862. PubMed ID: 34163353
    [No Abstract]   [Full Text] [Related]  

  • 34. Down regulation of RBM10 promotes proliferation and metastasis via miR-224-5p/RBM10/p53 feedback loop in lung adenocarcinoma.
    Sun X; Jia D; Yu Y
    Heliyon; 2024 Aug; 10(15):e35001. PubMed ID: 39144991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C; Rao X; Lin W
    Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
    Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
    Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy.
    Wang J; Cui X; Weng Y; Wei J; Chen X; Wang P; Wang T; Qin J; Peng M
    Front Genet; 2023; 14():1092968. PubMed ID: 36816016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
    Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
    Front Oncol; 2022; 12():904969. PubMed ID: 35978822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.